MUL1 and metabolic dysfunction-associated steatotic liver disease: To serve as a guide for future studies on medications that target ubiquitination and deubiquitination for the treatment of NAFLD, we present a review of the most recent research on E3 ubiquitin ligases (E3s) and deubiquitinating enzymes (DUBs) and their mechanism of action in NAFLD.